Abbott US diabetes device sales up 27% amid largely positive Q1 [Yahoo! Finance]
Insulet Corporation (PODD)
Last insulet corporation earnings: 2/25 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.insulet.com/investor-relations
Company Research
Source: Yahoo! Finance
The medtech giant posted an increase in year-over-year overall revenue of 4%, giving total takings of $10.36bn. After reporting a positive adjusted first-quarter profit of $1.09 per share, shares in the company rose 1% at market open today (16 April). Share prices rose further into the mid-morning. Abbott has a market cap $218.9bn. Abbott's medical device business was the strongest driver of revenue in the first quarter, driven by strong performance in the diabetes segment. A strong year for the company's diabetes devices led to a 16.5% sales increase compared to the same quarter in 2024. Abbott's US market saw a particularly high jump in growth – a 27% year-over-year change to bring diabetes sales in the US alone to $748m. This compares to $1.08bn generated internationally for the Diabetes Care unit. Sales of continuous glucose monitors (CGM), which includes the company's FreeStyle Libre range, grew 18.3% to reach $1.7bn. The company boosted manufacturing capacity for its diab
Show less
Read more
Impact Snapshot
Event Time:
PODD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PODD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PODD alerts
High impacting Insulet Corporation news events
Weekly update
A roundup of the hottest topics
PODD
News
- Insulet (NASDAQ:PODD) is now covered by analysts at Evercore ISI. They set an "outperform" rating and a $370.00 price target on the stock.MarketBeat
- Assessing Insulet (PODD) Valuation After Recent Share Price Pullback [Yahoo! Finance]Yahoo! Finance
- Insulet to Participate in 44th Annual J.P. Morgan Healthcare ConferenceBusiness Wire
- Insulet Expands Omnipod® U.S. Recycling Program, Diverting Millions of Pods from Landfills and Creating a More Sustainable Future [Yahoo! Finance]Yahoo! Finance
- Insulet Expands Omnipod® U.S. Recycling Program, Diverting Millions of Pods from Landfills and Creating a More Sustainable FutureBusiness Wire
PODD
Earnings
- 11/6/25 - Beat
PODD
Sec Filings
- 12/15/25 - Form 144
- 12/8/25 - Form 4
- 11/26/25 - Form 144
- PODD's page on the SEC website